{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:18:57Z","timestamp":1772047137182,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s174640","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T21:31:05Z","timestamp":1563399065000},"page":"5813-5822","source":"Crossref","is-referenced-by-count":28,"title":["&lt;p&gt;Update on elotuzumab for the treatment of relapsed\/refractory multiple myeloma: patients\u2019 selection and perspective&lt;\/p&gt;"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"Sabrina","family":"Trudel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Touzeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,7]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=51337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=51337","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T21:31:06Z","timestamp":1563399066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/update-on-elotuzumab-for-the-treatment-of-relapsedrefractory-multiple--peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s174640","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}